Brooklyn ImmunoTherapeutics
BTX
#6130
Rank
$0.03 B
Marketcap
$0.58
Share price
-4.07%
Change (1 day)
N/A
Change (1 year)

Revenue for Brooklyn ImmunoTherapeutics (BTX)

Revenue in : N/A

.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Brooklyn ImmunoTherapeutics from to

Annual revenue

Year Revenue Change

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$44.62 B inf%๐Ÿ‡ซ๐Ÿ‡ท France
$13.54 B inf%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.37 M inf%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.01 B inf%๐Ÿ‡ฆ๐Ÿ‡บ Australia
$15.08 B inf%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.07 B inf%๐Ÿ‡บ๐Ÿ‡ธ USA